Kengreal Interactions
There are 149 drugs known to interact with Kengreal (cangrelor), along with 1 disease interaction. Of the total drug interactions, 64 are major, 79 are moderate, and 6 are minor.
- View Kengreal disease interactions (1)
Medications known to interact with Kengreal
Note: Showing generic names only.
A
- abciximab
- abrocitinib
- acalabrutinib
- ado-trastuzumab emtansine
- aducanumab
- alemtuzumab
- alteplase
- anacaulase topical
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- avapritinib
B
C
- cabozantinib
- calaspargase pegol
- caplacizumab
- capsicum
- celecoxib
- chamomile
- cilostazol
- citalopram
- clomipramine
- clopidogrel
- clove
- collagenase clostridium histolyticum
D
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dipyridamole
- donanemab
- dong quai
- drotrecogin alfa
- duloxetine
E
F
- fenfluramine
- fenoprofen
- fenugreek
- feverfew
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
G
H
I
K
L
M
N
O
P
- panobinostat
- paroxetine
- pegaspargase
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- pirtobrutinib
- plasminogen, human
- ponatinib
- prasugrel
R
S
T
- tafasitamab
- tenecteplase
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
- turmeric
U
V
W
Z
Kengreal disease interactions
There is 1 disease interaction with Kengreal (cangrelor) which include:
More about Kengreal (cangrelor)
- Kengreal consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: platelet aggregation inhibitors
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.